Perioperative immunotherapy combined with standard therapy for human epidermal growth factor receptor 2-positive locally advanced gastric cancer: A case report
Large-scale phase III clinical trials are needed to verify the efficacy of combined neoadjuvant treatment application for GC.
Authors
- Xiaoting Ma (ORCID: https://orcid.org/0000-0003-1329-9761)
- Jianli Li (ORCID: https://orcid.org/0009-0005-9931-4839)
- Yi Ba
- Xicheng Wang (ORCID: https://orcid.org/0000-0001-6677-850X)
- Guangyu Yao
Institutions
- Changzhi Medical College (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
Publication Details
- Journal
- World Journal of Clinical Oncology
- Published
- 2025-11-21
- DOI
- https://doi.org/10.5306/wjco.v16.i11.112029
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00